Fenistil gel 1mg/g 30g №1

Name:
Fenistil gel Dnar.approx. 1mg in tubes 30g per pack. No. 1
Description:
Homogeneous gel, transparent or slightly opalescent, from colorless to pale yellow. The main active ingredient Dimetindene Release form 30 g in an aluminum tube, closed with a polyethylene cap. The tube, together with instructions for use, is packed in a cardboard box. Dosage 30 g Antihistamines for external use. ATC code: D04AA13 Pharmacodynamics Fenistil® gel is effective against itching of various origins, quickly relieves itching and reduces irritation. The action is due to the fact that, being an antagonist of histamine H1 receptors, dimethindene has a high affinity for H1 receptors and reduces capillary permeability, which is associated with an immediate hypersensitivity reaction. When applied topically, dimentinden maleate has a local anesthetic effect. The gel base of the drug facilitates the penetration of the active ingredient into the skin. Pharmacokinetics When applied topically, the drug begins to act after a few minutes. The maximum effect is achieved after 1-4 hours. Systemic bioavailability when applied topically is about 10% of the dose taken. Indications for use To relieve itching from insect bites and skin diseases of a small area: non-extensive mild sunburn, localized allergic skin diseases. Dosage and administration For adults and children over 2 years of age, the gel is applied to the affected area of the skin 2-4 times a day with a thin layer and gently rubbed. In children under the age of 2 years, the drug can be used only after consulting a doctor. Use during pregnancy and lactation Pregnancy In animal studies, no teratogenic effect was found, and no direct or indirect effect of dimethindene on the course of pregnancy, or on fetal development, or postnatal development was demonstrated. Clinical studies involving pregnant women have not been conducted. During pregnancy, caution should be exercised and Fenistil® gel should not be used on large areas of the skin, especially if there is inflammation or damage to the skin. Breastfeeding The same precautions should be followed as during pregnancy. During breastfeeding, the drug should also not be applied to the nipples of the mammary glands. Precautions In children under the age of 2 years, the drug should be used only as directed by a doctor. Use on large areas of skin should be avoided, especially in infants and young children. After applying the Fenistil® gel, avoid exposure to sunlight on the gel application area. Propylene Glycol: May cause localized skin irritation. Benzalkonium chloride: is an irritant and may cause skin reactions. Interaction with other drugs Interaction studies have not been conducted. Contraindications Hypersensitivity to any component that is part of the drug. The drug should not be used for therapy with a known allergy to insect bites (for this purpose, dosage forms available for systemic use are used). Composition Active substance: dimethindene maleate. 1 g of gel contains 1 mg of dimethindene maleate. Excipients: benzalkonium chloride, sodium edetate, carbomer 974 R, propylene glycol, sodium hydroxide, purified water. Overdose In case of accidental ingestion of a large amount of Fenistil® gel, the following symptoms may be observed, which are characteristic of an overdose of H1-antihistamines for systemic use: depression of the central nervous system with drowsiness (mainly in adults), stimulation of the central nervous system and anticholinergic effect (especially in children), accompanied by agitation, ataxia, hallucinations, tonic-clonic convulsions, mydriasis, dry mouth, flushing of the face, impaired urination, fever. Perhaps the development of arterial hypotension. The specific antidote is unknown. Conventional emergency medical measures should be taken, such as activated charcoal, saline laxatives, and measures to stabilize the respiratory and circulatory systems. Stimulants should not be used; vasopressors should be used to normalize blood pressure. Side effect Information on adverse reactions is presented according to system organ classes and frequency of occurrence in the following categories: very often (? 1/10), often (? 1/100, but <1/10), infrequently (? 1/1000 , but <1/100), rare (?1/10,000, but <1/1,000), very rare (<1/10,000), frequency unknown (cannot be estimated from the available data). The most frequently reported side effects are mild and short-term reactions at the site of application of the drug. Skin and subcutaneous tissue disorders: Infrequently - dryness, burning of the skin. Very rarely - allergic dermatitis. Reporting adverse reactions It is important to report suspected adverse reactions after registration of a medicinal product in order to ensure continuous monitoring of the benefit-risk balance of the medicinal product. Healthcare professionals are encouraged to report any suspected adverse drug reactions through national adverse drug reaction and drug failure reporting systems. If the patient experiences any adverse reactions, it is recommended to consult a doctor. This recommendation applies to any possible adverse reactions, including those not listed in the package insert. You can also report adverse reactions to the adverse drug reactions (actions) information database, including reports of drug failures. By reporting adverse reactions, you help to get more information about the safety of the drug. Storage conditionsStore at a temperature not exceeding 25 °C. Keep out of the reach of children. Buy Fenistil gel 1mg/g 30g №1 Price for Fenistil gel 1mg/g 30g №1